XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Jul. 31, 2020
Product Information [Line Items]      
Restricted Cash and Cash Equivalents $ 0 $ 0  
Compensating Balance, Amount 250,620  
Revenue, Remaining Performance Obligation, Amount 6,900,000    
Contract with Customer, Liability, Revenue Recognized 5,000,000.0 5,600,000  
Capitalized Contract Cost, Net $ 300,000 $ 300,000  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 52,678,020 50,851,655  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 2.90 $ 2.22  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.70    
Revenue from Contract with Customer, Excluding Assessed Tax $ 26,630,035 $ 28,902,550  
Series A Convertible Preferred Stock [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 43,483,062    
Series B Convertible Preferred Stock [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5,610,121    
Warrant [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 15,385    
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.70    
Stock Options and Stock Appreciation Rights [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,456,979    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 2.90    
Restricted Stock [Member]      
Product Information [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1,112,473    
Revenue From System Delivery and Installation [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 14.00% 7.00%  
Disposable Revenue [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 28.00% 33.00%  
Royalty Revenue [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 8.00% 10.00%  
Other Recurring Revenue [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 46.00% 47.00%  
Sublease Revenue [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 4.00% 3.00%  
Revenue from Contract with Customer Benchmark [Member] | Biosense Webster Inc [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage   1000.00%  
Revenue from Contract with Customer, Excluding Assessed Tax   $ 2,800,000  
Revenue from Contract with Customer Benchmark [Member] | Finland accounted [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 10.00%    
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,700,000    
Minimum [Member]      
Product Information [Line Items]      
Property, Plant and Equipment, Useful Life 3 years    
Finite-Lived Intangible Asset, Useful Life 10 years    
Maximum [Member]      
Product Information [Line Items]      
Property, Plant and Equipment, Useful Life 10 years    
Finite-Lived Intangible Asset, Useful Life 15 years    
Systems [Member]      
Product Information [Line Items]      
Money Market Funds, at Carrying Value $ 1,400,000    
Revenue from Contract with Customer, Excluding Assessed Tax 3,626,284 $ 2,066,253  
Systems [Member] | Maximum [Member]      
Product Information [Line Items]      
Product Warranty Expense $ 100,000    
Letter of Credit [Member]      
Product Information [Line Items]      
Long-term Line of Credit     $ 300,000
Compensating Balance, Amount     $ 300,000